B · Normal
September 8th, IONIS Pharmaceuticals’ stock price fell 13.1% before the market opened, after the company’s late-stage trial of a heart disease drug failed.
Related telegraphs
September 23rd: Apple is developing a new fitness tracker aimed at competing wit
09-23 00:23
On September 22, SpaceXAI announced that the number of users of its AI agent pro
09-22 23:26
On September 22, the S&P 500 Bank Index fell to its lowest level in more than th
09-22 23:24
On September 22, PayPal announced a partnership with Meta.
09-22 23:20
On September 22, Microsoft announced that it had successfully disrupted an AI-dr
09-22 23:10
On September 22, GameStop’s stock price hit a new high in more than four months,
09-22 23:01
Comments